Jakub Jończyk (Jakub Jonczyk)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Biomolecules

International journal of molecular sciences

Journal of enzyme inhibition and medicinal chemistry

Uniwersytet Jagiellonski w Krakowie Collegium Medicum

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uniwersytet Jagiellonski w Krakowie Collegium Medicum Oct 01 2014

Poland

PhD Student :: Department of Physicochemical Drug Analysis, Faculty of Pharmacy

Publications

Agnieszka Zagórska, Anna Czopek, Monika Fryc, Jakub Jończyk
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents. Biomolecules 14 (7) (2024)
Agnieszka Zagórska, Anna Czopek, Monika Fryc, Jakub Jończyk
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents. Biomolecules 14 (7) (2024)
Agnieszka Zagórska, Anna Czopek, Monika Fryc, Jakub Jończyk
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents. Biomolecules 14 (7) (2024)
Agnieszka Zagórska, Anna Czopek, Monika Fryc, Jakub Jończyk
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents. Biomolecules 14 (7) (2024)
Tomasz Kostrzewa, Jakub Jończyk, Joanna Drzeżdżon, Dagmara Jacewicz, Magdalena Gorska-Ponikowska, Marcin Kolaczkowski, Alicja Kuban-Jankowska
Synthesis, In Vitro, and Computational Studies of PTP1B Phosphatase Inhibitors Based on Oxovanadium(IV) and Dioxovanadium(V) Complexes. International journal of molecular sciences 23 (13) (2022)
Natalia Szałaj, Justyna Godyń, Jakub Jończyk, Anna Pasieka, Dawid Panek, Tomasz Wichur, Krzysztof Więckowski, Paula Zaręba, Marek Bajda, Anja Pišlar, Barbara Malawska, Raimon Sabatè, Anna Więckowska
Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer's disease. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Jakub Jończyk, Jędrzej Kukułowicz, Kamil Łątka, Barbara Malawska, Young-Sik Jung, Kamil Musilek, Marek Bajda
Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase. Biomolecules 11 (2) (2021)
Hyun Myung Lee, Rudolf Andrys, Jakub Jończyk, Kyuneun Kim, Avinash G Vishakantegowda, David Malinak, Adam Skarka, Monika Schmidt, Michaela Vaskova, Kamil Latka, Marek Bajda, Young-Sik Jung, Barbara Malawska, Kamil Musilek
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Kamila Czarnecka, Małgorzata Girek, Przemysław Wójtowicz, Paweł Kręcisz, Robert Skibiński, Jakub Jończyk, Kamil Łątka, Marek Bajda, Anna Walczak, Grzegorz Galita, Jacek Kabziński, Ireneusz Majsterek, Piotr Szymczyk, Paweł Szymański
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease. International journal of molecular sciences 21 (11) (2020)
Kamila Czarnecka, Małgorzata Girek, Paweł Kręcisz, Robert Skibiński, Kamil Łątka, Jakub Jończyk, Marek Bajda, Jacek Kabziński, Ireneusz Majsterek, Piotr Szymczyk, Paweł Szymański
Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease. International journal of molecular sciences 20 (3) (2019)

Jakub Jończyk.css-eqlu8i{font-size:small;padding-left:4px;} (Jakub Jonczyk)

Publication Activity (10 Years)

Top Topics

Top Venues

Jakub Jończyk (Jakub Jonczyk)